Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Investments
US microbiome discovery firm Bactana Animal Health has received $400,000 in financing from Connecticut Innovations.
Canadian company Avivagen has sourced Can$800,000 ($626,000) from the credit facility provided by Bloom Burton Healthcare Lending Trust.
Canadian veterinary diagnostics company Biovet has begun a Can$2.25 million ($1.75 million) expansion of its headquarters, with construction expected to be completed in July.
US parasite control company TyraTech has made progress in ramping up its product sales after it decided to focus solely on animal health.
US firm Man's Best Friend Therapeutics (MBFT) has receive $250,000 in funding from Benjamin Franklin Technology Partners.
The upcoming merger between leading veterinary distributor Henry Schein and Vets First Choice to create a diagnostics subsidiary has been welcomed by rival firm Heska.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.